-
Biocon’s Q3 revenue dips; banks on obesity drugs for future growth
30 Jan 2025 20:55 GMT
… ) – Indian biopharma company Biocon reported third-quarter revenue on … illnesses such as rheumatoid arthritis and cancer.
Show Full … -like basis, according to Biocon.
Its generics division, however … services business rose 11%.
Biocon, which expects a recovery …
-
Injectable Drug Delivery Devices Market Set for Strong Growth with a CAGR of 11.26% by 2030, Says DelveInsight
06 Feb 2025 15:16 GMT
Companies like Biocon, Becton, and Dickinson … include Eli Lilly and Company, Biocon, Becton, Dickinson & Company … , such as diabetes, rheumatoid arthritis, and multiple sclerosis. Injectable … like diabetes and rheumatoid arthritis, is also increasing the …
-
Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade
07 Jan 2025 10:52 GMT
… of Psoriasis Vulgaris and Psoriatic Arthritis (PsA).
Biocon Biologics previously notified the … approval.
In late November, Biocon Biologics announced that its ‘Embedding … and Drug Administration (USFDA) granted Biocon Biologics' Bengaluru facility “ …
-
Biocon Biologics secures PMDA approval for Ustekinumab biosimilar in Japan
07 Jan 2025 05:01 GMT
… collaboration is expected to strengthen Biocon Biologics’ foothold in the … markets globally.
The approval follows Biocon Biologics’ settlement and licensing agreement … for Psoriasis Vulgaris and Psoriatic Arthritis, offering significant relief from symptoms …
-
Biocon shares rise 3% as subsidiary secures Japanese PMDA approval for Ustekinumab biosimilar
07 Jan 2025 04:48 GMT
…
Key Highlights:
Regulatory Approval: Biocon Biologics received approval to market … like Psoriasis Vulgaris and Psoriatic Arthritis.
Commercial Partnership: The biosimilar … Collaboration: The approval follows Biocon Biologics’ licensing agreement with Janssen …
-
Itolizumab by Biocon for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
30 Dec 2024 18:27 GMT
… vitiligo, psoriatic arthritis, psoriasis, rheumatoid arthritis, multiple sclerosis, … dermatological disorders, refractory lupus nephritis and severe asthma.
Biocon … overview
Biocon is a biopharmaceutical …
-
EMA’s CHMP committee recommends approval of Biocon Biologics’ Yesintek
16 Dec 2024 10:18 GMT
Biocon Biologics (BBL), a fully integrated … biosimilars company and subsidiary of Biocon Ltd has announced that the … psoriasis and adults with psoriatic arthritis or Crohn’s disease - …
-
Stocks To Watch Today: Bharat Forge, Godrej Agrovet, Biocon, JSW Energy, Lupin And Others
16 Dec 2024 04:29 GMT
… session, stocks like Bharat Forge, Biocon, JK Paper, JSW Energy, … of Edgelab’s IPO plan.
Biocon
Biocon Biologics, a subsidiary of … , as well as psoriatic arthritis and Crohn’s disease in … : Bharat Forge, Godrej Agrovet, Biocon, JSW Energy, Lupin And Others
-
Biocon sells 80 lacs equity shares of Syngene International for Rs 686 crores
12 Dec 2024 16:25 GMT
… year for Biocon and subsequently its subsidiary Biocon Biologics to … Psoriasis and Psoriatic Arthritis.
Read also: USFDA approves Biocon Biologics Yesintek … Ulcerative Colitis, Plaque Psoriasis, Psoriatic Arthritis
Biocon Limited, publicly listed in 2004 …
-
Biocon Announces FDA Approval of Ustekinumab Biosimilar
09 Dec 2024 17:44 GMT
On December 1, 2024, Biocon announced that the FDA has … Psoriasis and Psoriatic Arthritis. According to the announcement, Biocon had entered into …